Hong Kong stocks surged: Conic Jerry Pharmaceuticals-B (09966.HK) up more than 5% as JSKN003 has been granted orphan drug qualification by the FDA for the treatment of GC/GEJ.

According to the Securities Times app, Kang Ning Jie Rui Pharmaceutical-B (09966.HK) rose by more than 5%, up 5.1% to HK$9.68 as of press time, with a turnover of HK$9.4489 million.